Collegium Pharmaceutical, Inc. ( COLL) - Stock Earnings
COLL Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
COLL Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 17.0 million USD | 205.4 million USD |
| 2026Q1 | 14.5 million USD | 193.5 million USD |
| 2026Q2 | -15.1 million USD | 199.9 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
COLL Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 48.2 million USD | 566.8 million USD |
| 2024 | 69.2 million USD | 631.4 million USD |
| 2025 | 62.9 million USD | 780.6 million USD |
| 2026 Est. | — | — |
COLL
Price: $23.19
Earnings Per Share: 1.27 USD
P/E Ratio: 21.42
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 465500
Ebitda: -13.3 millionMarket Capitalization: 711.3 million